Ophthalmic Drug Development Program
Ophthalmic drug development | Experts at Iris Pharma have the knowledge and expertise to guide new ophthalmic products through the ophthalmic drug development process
iris-pharma.comCrawled Nov 18, 2026
Ophthalmic drug development | Experts at Iris Pharma have the knowledge and expertise to guide new ophthalmic products through the ophthalmic drug development process
Age-related macular degeneration research (AMD): Iris Pharma offers preclinical models of Age-related macular degeneration (AMD) and clinical research services.
Iris Pharma| Cataract research and postoperative inflammation following cataract surgery | Iris Pharma offers preclinical research and clinical trial services.
Iris Pharma offers preclinical models of conjunctivitis - who is an infection of the conjunctiva - and clinical research services
Diabetic retinopathy (DR) research: Iris Pharma offers preclinical models of diabetic retinopathy (DR) and clinical research services
Iris Pharma demonstrates a deep expertise in many eye conditions and ocular clinical problems including AMD, DR, dry eye, glaucoma, uveitis and conjunctivitis
Streetlab signed a strategic partnership with Iris Pharma, a contract research organization specializing in preclinical and clinical ophthalmology research
Experimental Autoimmune Uveitis (EAU) in rat serves as a model of certain ocular inflammatory pathologies in human
The new facilites supports the growing number of demands for ocular preclinical studies to improve the high level of flexibility, responsiveness and service quality.
Keen Eye and Iris Pharma team up to bring AI in the preclinical ophthalmic drug development to make assays faster, more reliable and more efficient.
Iris Pharma shares ophthalmic and in vivo pharmacology news, event calendars, and financial information
Streetlab and Iris Pharma: a Partnership Aimed at Integrating Quality of Life in the Clinical Assessment of New Products for Use by the Visually Impaired
Pierre Paul Elena founded Iris Pharma and the Ophta Biotech association
A link between the academic/industrial sectors to reinforce the continuum from the stage of the underlying research through to treatment of visually impaired patient
Contract research services in ophthalmology. Iris Pharma is a world leading clinical and preclinical contract research organization (CRO) for research in ophthalmology
The Institut de la Vision and Iris Pharma collaborate to strengthen public-private ties between industry and academic research
Iris Pharma’s labs feature advanced equipment for in vivo pharmacology, toxicology, and drug safety studies
Iris Pharma obtains renewal of its accreditation for the research tax credit (CIR) by the French Ministry Responsible for Research
Iris Pharma is a world-leading Contract Research Organization (CRO) offering drug and device development services in ophthalmology
Iris Pharma accelerates the development of new therapies to benefit patients with impaired vision and suffering from ocular ailments.
Iris Pharma, a Contract Research Organization, provides preclinical and clinical research in ophthalmology: ocular safety, efficacy, ocular pharmacokinetics, clinical trials, bioanalytical testing
The information is given for information purposes only; it can be modified without prior notification and has no contractual value.